|
|
| DIG |
|
|
September 24, 2010 Advisory: Monobind has upgraded Digoxin to a HRP-based system which uses a streptavidin plate. Effective Oct 2010, all shipments will include this new format. Please see new IFU on ELISA page.
Digoxin is a cardiac drug given to treat patients with congestive heart failure, angina and arrythmias. This drug must be monitored in patients to allow proper dose adjustment and prevent toxicity. Digoxin concentrations should be measured at least eight hours after an oral dose and ideally when concentrations have reached steady state. |
|
Our ready made kits for infectious
diseases, thyroid and reproductive
endochrinologies, tumor, and cardiac
markers, and other human disease-
states enable you to quickly and reliably
ascertain results for your patient samples.
Our ready made kits for infectious
diseases, thyroid and reproductive
endochrinologies, tumor, and cardiac
markers, and other human disease-
states enable you to quickly and reliably
ascertain results for your patient samples.
|
|
|
|
|
